vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Thermon Group Holdings, Inc. (THR). Click either name above to swap in a different company.

Thermon Group Holdings, Inc. is the larger business by last-quarter revenue ($147.3M vs $89.1M, roughly 1.7× HARROW, INC.). Thermon Group Holdings, Inc. runs the higher net margin — 12.4% vs 7.4%, a 5.0% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 9.6%). Thermon Group Holdings, Inc. produced more free cash flow last quarter ($13.1M vs $8.1M).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Thermon Group Holdings, Inc. is a global provider of engineered thermal management solutions, specializing in heat tracing systems, heating cables, temperature monitoring controls, and associated installation support services. It serves core industrial segments including oil and gas, chemical processing, power generation, and food and beverage, with operating bases across North America, Europe, Asia-Pacific, and Latin America.

HROW vs THR — Head-to-Head

Bigger by revenue
THR
THR
1.7× larger
THR
$147.3M
$89.1M
HROW
Growing faster (revenue YoY)
HROW
HROW
+23.7% gap
HROW
33.3%
9.6%
THR
Higher net margin
THR
THR
5.0% more per $
THR
12.4%
7.4%
HROW
More free cash flow
THR
THR
$5.0M more FCF
THR
$13.1M
$8.1M
HROW

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HROW
HROW
THR
THR
Revenue
$89.1M
$147.3M
Net Profit
$6.6M
$18.3M
Gross Margin
79.3%
46.6%
Operating Margin
17.5%
18.1%
Net Margin
7.4%
12.4%
Revenue YoY
33.3%
9.6%
Net Profit YoY
-2.2%
-1.3%
EPS (diluted)
$0.20
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
THR
THR
Q4 25
$89.1M
$147.3M
Q3 25
$71.6M
$131.7M
Q2 25
$63.7M
$108.9M
Q1 25
$47.8M
Q4 24
$66.8M
Q3 24
$49.3M
Q2 24
$48.9M
Q1 24
$34.6M
Net Profit
HROW
HROW
THR
THR
Q4 25
$6.6M
$18.3M
Q3 25
$1.0M
$15.0M
Q2 25
$5.0M
$8.6M
Q1 25
$-17.8M
Q4 24
$6.8M
Q3 24
$-4.2M
Q2 24
$-6.5M
Q1 24
$-13.6M
Gross Margin
HROW
HROW
THR
THR
Q4 25
79.3%
46.6%
Q3 25
75.3%
46.4%
Q2 25
74.5%
44.1%
Q1 25
67.5%
Q4 24
78.8%
Q3 24
75.6%
Q2 24
74.4%
Q1 24
69.5%
Operating Margin
HROW
HROW
THR
THR
Q4 25
17.5%
18.1%
Q3 25
20.6%
16.4%
Q2 25
17.9%
10.8%
Q1 25
-23.5%
Q4 24
19.3%
Q3 24
2.7%
Q2 24
3.1%
Q1 24
-20.0%
Net Margin
HROW
HROW
THR
THR
Q4 25
7.4%
12.4%
Q3 25
1.4%
11.4%
Q2 25
7.8%
7.9%
Q1 25
-37.2%
Q4 24
10.1%
Q3 24
-8.6%
Q2 24
-13.2%
Q1 24
-39.2%
EPS (diluted)
HROW
HROW
THR
THR
Q4 25
$0.20
$0.55
Q3 25
$0.03
$0.45
Q2 25
$0.13
$0.26
Q1 25
$-0.50
Q4 24
$0.19
Q3 24
$-0.12
Q2 24
$-0.18
Q1 24
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
THR
THR
Cash + ST InvestmentsLiquidity on hand
$72.9M
$46.9M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$538.7M
Total Assets
$399.5M
$816.7M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
THR
THR
Q4 25
$72.9M
$46.9M
Q3 25
$74.3M
$29.7M
Q2 25
$53.0M
$36.5M
Q1 25
$66.7M
Q4 24
$47.2M
Q3 24
$72.6M
Q2 24
$71.0M
Q1 24
$76.0M
Total Debt
HROW
HROW
THR
THR
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
THR
THR
Q4 25
$52.4M
$538.7M
Q3 25
$47.0M
$515.2M
Q2 25
$49.7M
$509.3M
Q1 25
$56.5M
Q4 24
$69.7M
Q3 24
$58.0M
Q2 24
$58.5M
Q1 24
$60.6M
Total Assets
HROW
HROW
THR
THR
Q4 25
$399.5M
$816.7M
Q3 25
$363.1M
$778.2M
Q2 25
$345.0M
$765.3M
Q1 25
$364.2M
Q4 24
$389.0M
Q3 24
$351.5M
Q2 24
$306.6M
Q1 24
$295.5M
Debt / Equity
HROW
HROW
THR
THR
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
THR
THR
Operating Cash FlowLast quarter
$8.4M
$18.0M
Free Cash FlowOCF − Capex
$8.1M
$13.1M
FCF MarginFCF / Revenue
9.1%
8.9%
Capex IntensityCapex / Revenue
0.4%
3.3%
Cash ConversionOCF / Net Profit
1.27×
0.98×
TTM Free Cash FlowTrailing 4 quarters
$43.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
THR
THR
Q4 25
$8.4M
$18.0M
Q3 25
$16.6M
$7.4M
Q2 25
$-803.0K
$10.7M
Q1 25
$19.7M
Q4 24
$-17.8M
Q3 24
$3.0M
Q2 24
$-2.7M
Q1 24
$-4.6M
Free Cash Flow
HROW
HROW
THR
THR
Q4 25
$8.1M
$13.1M
Q3 25
$16.4M
$4.4M
Q2 25
$-969.0K
$8.3M
Q1 25
$19.5M
Q4 24
$-18.3M
Q3 24
$2.3M
Q2 24
$-3.1M
Q1 24
$-4.7M
FCF Margin
HROW
HROW
THR
THR
Q4 25
9.1%
8.9%
Q3 25
22.9%
3.3%
Q2 25
-1.5%
7.6%
Q1 25
40.8%
Q4 24
-27.4%
Q3 24
4.8%
Q2 24
-6.3%
Q1 24
-13.6%
Capex Intensity
HROW
HROW
THR
THR
Q4 25
0.4%
3.3%
Q3 25
0.3%
2.3%
Q2 25
0.3%
2.2%
Q1 25
0.4%
Q4 24
0.8%
Q3 24
1.2%
Q2 24
0.7%
Q1 24
0.3%
Cash Conversion
HROW
HROW
THR
THR
Q4 25
1.27×
0.98×
Q3 25
16.26×
0.50×
Q2 25
-0.16×
1.25×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

THR
THR

Other$73.7M50%
Transferred At Point In Time$56.1M38%
Transferred Over Time$17.5M12%

Related Comparisons